TBI - TrueBlue, Inc. Stock Analysis | Stock Taper
Logo
TrueBlue, Inc.

TBI

TrueBlue, Inc. NYSE
$6.21 1.47% (+0.09)

Market Cap $188.81 M
52w High $7.78
52w Low $3.18
P/E -3.47
Volume 195.21K
Outstanding Shares 30.40M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q1-2026 $398.57M $85.25M $-19.8M -4.97% $-0.66 $-5.28M
Q4-2025 $418.18M $95.45M $-31.54M -7.54% $-1.06 $-4.38M
Q3-2025 $431.27M $98.04M $-1.92M -0.44% $-0.06 $7.2M
Q2-2025 $396.3M $96.5M $-160K -0.04% $-0.01 $4.76M
Q1-2025 $370.25M $100.47M $-14.35M -3.88% $-0.48 $-7.31M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q1-2026 $24.13M $620.67M $364.59M $256.08M
Q4-2025 $24.51M $638.67M $364.11M $274.56M
Q3-2025 $19.89M $690.53M $386.19M $304.34M
Q2-2025 $21.9M $672.78M $367.59M $305.19M
Q1-2025 $23.06M $692.47M $390.25M $302.22M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q1-2026 $-19.8M $-9.78M $3.22M $7.17M $293K $-12.61M
Q4-2025 $-31.54M $-4.37M $30K $-2.45M $4.62M $-7.49M
Q3-2025 $-1.92M $-19.77M $3.7M $14.47M $-1.66M $-23.38M
Q2-2025 $-160K $-11.79M $4.18M $-4.25M $-11.71M $-16.05M
Q1-2025 $-14.35M $-22.11M $-23.97M $49.37M $3.06M $-26.8M

Revenue by Products

Product Q2-2025Q3-2025Q4-2025Q1-2026
PeopleManagement
PeopleManagement
$130.00M $130.00M $140.00M $130.00M
PeopleReady
PeopleReady
$210.00M $250.00M $230.00M $230.00M

Q1 2026 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at TrueBlue, Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Key positives include a diversified set of staffing and workforce solutions brands, well‑developed digital platforms that improve client and worker experiences, and a long operating history with large enterprises across multiple sectors. The company has shown in the recent past that it can generate healthy margins and strong cash flow when conditions are favorable. Its push into higher‑value areas like healthcare staffing and its reputation for ethical practices also support customer trust and open doors to more resilient end markets.

! Risks

Major risks stem from the combination of declining revenue, sustained operating losses, and negative cash flow. The shrinking asset and equity base, rising leverage, and weaker liquidity mean the balance sheet is less able to absorb further shocks. Competitive intensity from both traditional staffing firms and digital platforms could keep pressure on pricing and volumes. Execution risk around cost restructuring, technology monetization, and integration of new verticals such as healthcare is high, especially when financial flexibility is constrained.

Outlook

The forward picture is mixed and uncertain. On one hand, TrueBlue has meaningful assets in technology, brand diversity, and sector reach that could support a recovery if economic conditions improve and its strategic initiatives in sales expansion, partnerships, and healthcare staffing gain traction. On the other hand, the current financial trajectory—shrinking revenue, thin or negative margins, weaker cash generation, and higher debt—indicates that the company is in a challenging transition. The medium‑term outlook largely depends on its ability to stabilize volumes, rebuild profitability, and convert its innovation and diversification efforts into durable, cash‑generating growth while carefully managing financial risk.